TABLE 2.
Control subjects (n = 7)2 |
Partial-OTCD subjects (n = 7)2 |
P values |
||||||
Item | Control | Phenylbutyrate | Control | Phenylbutyrate | Pooled SEM | TRT | Gen | TRT × Gen |
Flux (μmol · kg−1 · h−1) | ||||||||
Urea | 180 | 156 | 157 | 121 | 11.0 | <0.012 | <0.017 | <0.600 |
Phenylalanine | 49 | 50 | 46 | 43 | 2.9 | <0.778 | <0.062 | <0.503 |
Tyrosine | 44 | 51 | 47 | 45 | 3.0 | <0.358 | <0.738 | <0.169 |
Leucine | 114 | 128 | 114 | 127 | 8.7 | <0.467 | <0.432 | <0.371 |
Glutamine | 266 | 299 | 281 | 263 | 19.3 | <0.709 | <0.587 | <0.201 |
CO2 (×100) | 143 | 135 | 140 | 134 | 13.2 | <0.607 | <0.895 | <0.932 |
Clearance (mL plasma/min) | ||||||||
Phenylalanine | 10.5 | 11.7 | 10.1 | 9.2 | 0.77 | <0.800 | <0.180 | <0.014 |
Tyrosine | 11.5 | 11.7 | 9.7 | 8.5 | 1.2 | <0.583 | <0.129 | <0.426 |
Leucine | 14.5 | 23.7 | 17.2 | 25.0 | 2.69 | <0.001 | <0.539 | <0.736 |
Glutamine | 7.8 | 9.2 | 6.6 | 6.7 | 0.65 | <0.082 | <0.051 | <0.116 |
Rate of conversion (μmol · kg−1 · h−1) | ||||||||
Gln→urea | 45a | 33a,b | 51a | 22b | 4.6 | <0.001 | <0.711 | <0.011 |
Phe→Tyr | 7 | 8 | 8 | 8 | 0.6 | <0.980 | <0.377 | <0.403 |
Leu→CO2 | 43 | 45 | 46 | 44 | 3.7 | <0.903 | <0.816 | <0.578 |
TRT, treatment (control compared with phenylbutyrate treatments); Gen, genotype (control compared with partial-OTCD subjects); TRT × Gen, interaction of main effects; Gln→urea, rate of transfer of the amido group of glutamine to urea; Phe→Tyr, rate of conversion of phenylalanine to tyrosine; Leu→CO2, rate of conversion of leucine to carbon dioxide. Data were analyzed by using mixed models (fixed effects for TRT, Gen, and TRT × Gen; random effects for subject). Values with different superscript letters differed (Tukey-Kramer–adjusted P < 0.05).
Values are means.